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Background: Cumulating evidence underlines the role of adipose tissue metallothionein (MT) in the development of
obesity and type 2 diabetes. Fasting/refeeding was shown to affect MT gene expression in the rodent liver. The influence
of nutritional status on MT gene expression in white adipose tissue (WAT) is inconclusive. The aim of this study was to
verify if fasting and fasting/refeeding may influence expression of MT genes in WAT of rats.
Results: Fasting resulted in a significant increase in MT1 and MT2 gene expressions in retroperitoneal, epididymal, and
inguinal WAT of rats, and this effect was reversed by refeeding. Altered expressions of MT1 and MT2 genes in all main fat
depots were reflected by changes in serum MT1 and MT2 levels. MT1 and MT2 messenger RNA (mRNA) levels in WAT
correlated inversely with serum insulin concentration. Changes in MT1 and MT2 mRNA levels were apparently not related
to total zinc concentrations and MTF1 and Zn transporter mRNA levels in WAT. Fasting or fasting/refeeding exerted no
effect on the expression of MT3 gene in WAT. Addition of insulin to isolated adipocytes resulted in a significant decrease
in MT1 and MT2 gene expressions. In contrast, forskolin or dibutyryl-cAMP (dB-cAMP) enhanced the expressions of MT1
and MT2 genes in isolated adipocytes. Insulin partially reversed the effect of dB-cAMP on MT1 and MT2 gene expressions.
Conclusions: This study showed that the expressions of MT1 and MT2 genes in WAT are regulated by nutritional status,
and the regulation may be independent of total zinc concentration.
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Metallothioneins (MTs) constitute the family of cysteine-
and metal-rich, low molecular mass (61 to 68 amino acid)
single-chain proteins [41, 47]. Four MT isoforms, MT1,
MT2, MT3, and MT4, were found in mammals [47]. MT1
and MT2 are predominant isoforms expressed in many
animal tissues. MT1 and MT2 expression is induced by
several factors including metals, some drugs, glucocorti-
costeroids, oxidative stress, and inflammatory mediators
[47]. MT3 (also referred to as growth inhibitory factor
(GIF)) and MT4 genes are expressed in the brain (pre-
dominantly in Zn-containing neurons of the hippocam-
pus, pineal gland, and retina) and stratified squamous
epithelial cells [1, 14, 47]. Expression of MT3 was also* Correspondence: juls@gumed.edu.pl
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MT3 and MT4 are often referred to as non-inducible pro-
teins [47], some data imply that also MT3 may be, at least
in part, an inducible protein, and its expression is modu-
lated by metal concentrations [14]. While all MT isoforms
show similar metal binding capacities, they likely have dif-
ferent biological functions. Available evidence suggests
that MT1 and MT2 may be involved in (a) protection
against heavy metal- and reactive oxygen species-induced
toxicity [36], (b) Zn and Cu homeostasis, as they sequester
and/or dispense Zn and Cu [40], and (c) acute phase re-
sponse [4]. Noticeably, however, mice with disrupted MT1
and MT2 genes were viable and developed normally
under standard conditions, despite greater susceptibility
to cadmium toxicity [31]. Moreover, it has been suggested
that the increased level of MT1 in mice might have an
important role in reducing morbidity in old animals [29].
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postulated to play a role in the prevention of cardiomyop-
athy [5, 6] and intermittent hypoxia-induced renal injury
[50]. Relatively little is known about the biological func-
tions of MT3 and MT4. MT3 knockout mice developed
normally under standard conditions but were more sus-
ceptible to kanic acid-induced seizures and showed a
greater degree of resultant hippocampal neuronal injury
[15]. The potential role of MT3 in the progression of neu-
rodegenerative diseases still raises some controversies;
while according to some authors MT3 acts as a protective
factor against neurodegenerative diseases, others showed
that it may stimulate progression thereof [1, 14, 19, 22].
The evidence from in vivo studies suggests that ectopic
expression of MT3 encoding gene stimulates pancreatic
acinar necrosis; however, the molecular basis for this toxic
effect is unknown [34]. MT4 is likely involved in the
regulation of Zn metabolism during the differentiation
of epithelial cells [33].
The list of tissues/organs that express MTs encod-
ing genes includes also brown and white adipose tis-
sue [3, 43, 45]. Some evidence from animal studies implies
that MT1 and MT2 may be involved in the regulation of
energy balance [2]. Furthermore, these MTs may play a
role in the prevention of high-fat diet-induced obesity
[37]. Moreover, human studies documented enhanced ex-
pression of MT2a encoding gene in adipose tissue from
an obese subject [7, 11] and patients with type 2 diabetes
[16]. This implies that the upregulation of MT gene ex-
pression in human adipose tissue may exert a detrimental
effect promoting obesity or be a consequence of obesity.
In view of data mentioned above, further studies are
needed to establish whether MTs really play a role in the
etiopathogenesis of obesity and type 2 diabetes. Both these
conditions are strongly influenced by the amount of
consumed food [18] and intracellular zinc homeostasis
[38, 42, 46, 48]. Among other factors, intracellular zinc
homeostasis is regulated by MTs [8, 26, 30]. It has been
shown that overexpression of MTs quickly diminishes
intracellular zinc concentration in cell culture [28].
Thus, it is likely that overexpression of genes coding MT
in vivo could decrease zinc concentration in adipocytes,
and subsequently biosynthesis of zinc finger proteins,
which are the important transcription factors regulating
adipogenesis, obesity, and related diseases [48].
Higashimoto et al. [17] and Kondoh et al. [25] found
that the liver content of MTs in fasted mice increases
significantly, perhaps due to starvation-stimulated syn-
thesis of MTs. In contrast, fasting and refeeding exert no
effect on MT1 gene expression in epididymal white adi-
pose tissue of mice [43, 45]. Surprisingly, a significant
increase in MT gene expression was observed in a
primary culture of rat adipocytes incubated with
cAMP or insulin [44]. The abovementioned discrepanciesbetween the results of in vivo (especially, no effect of
fasting and fasting/refeeding on MT gene expression
in white adipose tissue (WAT)) and in vitro studies
(stimulatory effect of cAMP and insulin on MTs
genes in primary adipocyte culture) require further
clarification.
The aim of this study was to analyze factors that po-
tentially may regulate expression of genes coding MTs
in rat WAT. We concentrated especially on the effects
of fasting and fasting/refeeding on MT gene expression
in main fat depots of rats, as well as an effect of insulin
and cAMP on MT messenger RNA (mRNA) levels in
isolated adipocytes.
Methods
Animals and treatment, tissue and blood collection
The experiment included 10-week-old male Wistar
rats. The animals were housed at 22 °C in individual
wire-mesh cages, under a 12:12 h light to dark cycle
with lights on at 7:00 a.m. The rats were randomly
assigned to seven groups (10 animals each): (a) con-
trol (ad libitum-fed animals with free access to food
and tap water); (b) fasted for 24, 48, or 72 h, and (c)
fasted for 48 h and then refed ad libitum for 12, 24,
or 48 h.
The rats were killed by decapitation (between 8:00
and 10:00 a.m.). White adipose tissue: retroperitoneal,
epididymal, and inguinal, as well as liver and esopha-
gus, were harvested, weighed, and frozen in liquid
nitrogen immediately upon collection and stored
at −80 °C until analysis. Blood samples were obtained
from the cervical artery. After 1 h, the blood cells
were removed by centrifugation at 1500×g for 10 min.
Obtained serum samples were stored at −80 °C until
analysis.
All institutional and national guidelines for the care
and use of laboratory animals were followed.
The study was approved by the Local Ethics Com-
mittee for Experimental Animals in Gdansk, Poland
(14/2012).
Isolation and primary culture of rat adipocytes
Adipocytes from epididymal WAT of 10-week-old male
rats were isolated by collagenase digestion as described by
[35]. The tissue was placed in polypropylene tubes with
Krebs-Ringer buffer (37 °C) containing 1 % bovine serum
albumin suitable for cell culture (Sigma-Aldrich, USA),
5.5-mM glucose, 20-mM HEPES (pH 7.6), and 1-mg/ml
collagenase (type II; Sigma-Aldrich, USA). The tissue was
finely cut with scissors and incubated at 37 °C for 1 h with
continuous shaking. After the incubation, the tissue was fil-
tered using 180-μm nylon filters. Adipocytes were washed
three times with Krebs-Ringer buffer. The adipocytes iso-
lated from each rat were divided into equal portions and
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ml Dulbecco’s modified Eagle’s medium (DMEM) (Sigma-
Aldrich, USA) with 5.5-mM glucose supplemented with
1 % bovine serum albumin. The adipocytes were incubated
at 37 °C (under 5 % CO2 plus 95 % O2) for 24 h: (a) with-
out addition (control) or (b) in the presence of insulin
(10 μg/ml), (c) forskolin (12 μM) (Sigma-Aldrich, USA),
(d) 0.2-mM dibutyryl-cAMP (dB-cAMP) (Sigma-Al-
drich, USA), and (e) insulin (10 μg/ml) plus dB-cAMP
(0.2 mM).
RNA isolation
Total RNA (from rat adipose tissue and liver, as well as
from isolated adipocytes) was extracted using the Purezol
reagent (Bio-Rad, USA) according to the manufacturer’s
protocol. Concentration of the RNA was determined on
the basis of absorbance at 260 nm. All samples had 260/
280 nm absorbance ratio of approximately 2.0.
Reverse transcription
First-strand complementary DNA (cDNA) was synthe-
sized from 4 μg of total RNA (RevertAidTM First Strand
cDNA Synthesis Kit; Thermo Scientific, USA). Prior to
amplification of cDNA, each RNA sample was treated
with RNase-free DNase I (Thermo Scientific, USA) at
37 °C for 30 min.
Real-time PCR
Real-time PCR amplification was performed in a 20-μl
volume using iQ SYBR Green Supermix (Bio-Rad, USA).
Each reaction mix contained cDNA and 0.3 μM of each
primer. Primers were designed using Primer-BLAST soft-
ware (NCBI, USA) and synthesized at Genomed (Poland).
Forward and reverse primer sequences are presented in
supplementary material (Additional file 1: Table S1). The
samples were incubated at 95 °C for 5 min to obtain an
initial denaturation and polymerase activation, followed
by 35 PCR cycles of amplification (92 °C for 20 s, 57 °C
for 20 s, and 72 °C for 40 s). Control reactions, with omis-
sion of the RT step or with no template cDNA added,
were performed for each assay. All the samples were run
in triplicate. To adjust for variations in the amount of
added RNA and efficiency of the reverse transcription,
β-actin, cyclophilin, and TBP mRNAs were quantified
in corresponding samples of WAT and liver, and the re-
sults were normalized to these values. Since the results
regarding MT mRNA levels in WAT and liver obtained
with β-actin, cyclophilin, and TBP were essentially
similar, we presented the relative gene expression only
as precisely corresponding mRNA/β-actin mRNA in the
“Results” section. Relative quantities of the transcripts were
calculated using the 2−ΔΔCT formula [27]. The results are
expressed in arbitrary units, with one unit corresponding
to mean mRNA level for the control group. Amplificationof specific transcripts was further confirmed by obtaining
melting curve profiles and subjecting the amplification
products to 1 % agarose gel electrophoresis.
Western blots
Western blots were performed as recently described
[39]. Briefly, frozen liver or adipose tissue were homog-
enized in 20-mM Tris-HCl buffer (pH 7.8) containing
0.2 % Triton X-100 and protease inhibitor cocktail
(Sigma-Aldrich, USA) and centrifuged (30 000×g for
20 min). Aliquots of the supernatants containing 20-μg
protein (estimated by Lowry’s method) and the molecular
mass protein markers were separated by 10 % SDS-PAGE
and electroblotted to Immun-Blot PVDF Membrane (Bio-
RAD, USA). The membranes were blocked with 5 % albu-
min in phosphate buffered saline (PBS) with 0.05 % Tween
20 (Sigma-Aldrich, USA). Subsequently, the membranes
were incubated with antibodies diluted in blocking buffer.
Monoclonal mouse antibodies against both MT1 and
MT2 (MT1/2) (UC1MT) were purchased from Abcam
(GB). Anti-actin (A5060), as well as HRP-conjugated sec-
ondary anti-rabbit (A0545) and anti-mouse antibodies
(A9044), was obtained from Sigma-Aldrich (USA). The
bands were visualized using ChemiDoc XRS (Bio-Rad,
USA) and compared with respective molecular mass pro-
tein markers (SM26634) obtained from Thermo Scientific
(USA), visualized on the membrane after electroblotting.
Serum samples were diluted with 20-mM Tris-HCl buf-
fer (pH 7.8), and aliquots of the diluted solution contain-
ing 20-μg serum protein (protein estimated by Lowry’s
method) were separated by 10 % SDS-PAGE and electro-
blotted to Immun-Blot PVDF Membrane (Bio-RAD,
USA). Further steps of western blots were performed as
described above for liver or adipose tissue samples.
Serum insulin concentration assay
Serum insulin concentrations were determined by enzyme-
linked immunosorbent assay (ELISA) (RAI008R; Biovendor,
Czech Republic).
Determination of total zinc levels in adipose tissues
The total amount of Zn in adipose tissues was deter-
mined by flame atomic absorption spectrometry (spec-
trometer AAnalyst 400 Perkin Elmer) after dry ashing
at 450 °C. Approximately 0.3 g of epididymal adipose tis-
sue was combusted with gradual increase of temperature
(50 °C/h). The obtained ash was treated with 5 ml of
hydrochloric acid (6 M), and then, the acid solution was
evaporated to dryness. The obtained residue was dissolved
in 5 ml of nitric acid (0.1 M) and used for zinc determin-
ation at 213.9 nm. All analyses were done in triplicate.
The accuracy and precision of the used method was as-
sured by simultaneous analysis of certified reference ma-
terial M-3 HerTis (Herring Tissue).
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Statistical significance of intergroup differences was veri-
fied on the basis of one-way analysis of variance (ANOVA)
with Tukey’s post hoc test. If data were not normally dis-
tributed, they were verified by non-parametric Kruskal–
Wallis test. Pearson’s correlation coefficient was calculated
to assess the correlation between body weight or adipose
tissue mass and relative MT mRNA level. All results are
presented as means ± standard deviations (SD). The differ-
ences were considered significant at p < 0.05. Sigma Stat
software was used for all statistical analyses.Results
Using real-time PCR, we detected MT1, MT2, and MT3
mRNA in epididymal, retroperitoneal, and inguinal white
adipose tissue (Fig. 1). MT4 mRNA was not found in
any of the main fat depots (Fig. 1). The esophagus
served as a positive control for MT4 mRNA (Fig. 1). As
expected, in the liver, no MT3 mRNA was found (Fig. 1).
After a 24-h fast, a significant increase in MT1 (Fig. 2a)
and MT2 (Fig. 2b) mRNA levels was observed in epi-
didymal, retroperitoneal, and inguinal WAT. After a 48-
h fast, MT1 and MT2 mRNA levels in epididymal and
retroperitoneal WAT were several-fold higher than in
the controls (Fig. 2a, b). Fasting exerted less prominent
effects on MT1 and MT2 mRNA levels in inguinal WAT
(Fig. 2a, b), what points to likely differences in fastingFig. 1 Detection of MT1, MT2, MT3, and MT4 mRNA in the liver, main
pads of WAT (epididymal, retroperitoneal, inguinal), and the esophagus
of rats by real-time PCR analysis. TBP-TATA-binding proteinresponse of various WAT depots. The effects of a 72-h
fast on MT1 and MT2 mRNA levels in WAT were com-
parable to those observed after 48 h (Fig. 2a, b). Fasting
exerted no significant effects on MT3 mRNA levels in any
of the main fat depots (Fig. 2c). An increase in MT1 and
MT2 mRNA levels was observed for liver MTs (Fig. 3).
The differences in MT1 and MT2 mRNA levels in the
WAT and liver of control and fasted rats were reflected by
their WAT, liver, and serum MT1 and MT2 protein levels
determined by western blot analysis (Fig. 4). When the
rats were fed ad libitum after a 48-h fast, their MT1
mRNA levels in retroperitoneal, epididymal, and inguinal
WAT were normalized within 12 h (Fig. 5a). Similar ef-
fects were also observed for MT2 mRNA levels in retro-
peritoneal, epididymal, inguinal WAT (Additional file 2:
Table S2) and liver MT1 and MT2 (Fig. 5b, c, respect-
ively). Fasting/refeeding exerted no effects on MT3 mRNA
levels in any of the main WAT depots (Additional file 2:
Table S2). The differences in MT1 and MT2 mRNA levels
in the WATand liver of fasted and refed rats were consist-
ent with the differences in their WAT and liver MT1 and
MT2 protein levels determined by western blot analysis
(Fig. 5d). Changes in MT1 and MT2 mRNA as well as
protein levels apparently were not related to the epididy-
mal WAT total zinc concentrations expressed as μg/mg
protein (Fig. 5e) or as μg/g tissue (Additional file 3: Table
S3). Moreover, in contrast to MT1 and MT2 mRNA and
proteins, ZnT1 mRNA (Fig. 5f) and MTF1 mRNA (Fig. 5g)
levels were not affected by fasting or fasting/refeeding.
It should be mentioned that others examined Zn trans-
porter mRNAs like ZnT6, ZnT9, ZIP6, ZIP8, and ZIP14
were also not affected by fasting or fasting/refeeding
(Additional file 4: Table S4). Thus, the data presented
on Fig. 5 suggest that the changes induced by fasting or
fasting/refeeding in MT1 and MT2 mRNA levels may
be independent of zinc. Body and fat mass (sum of
retroperitoneal + epididymal + inguinal WAT) for con-
trol (not treated), fasted, and fasted/refed rats are pre-
sented in Table 1. Based on data presented in Fig. 2 and
Table 1, correlation coefficient between body mass and
MT mRNA levels as well between fat mass and MT
mRNA levels was calculated. As indicated in Table 2,
there was a negative correlation between MT1 mRNA
level and body mass or fat mass. Essentially similar cor-
relation for MT2 mRNA was found. As expected, no
correlation was revealed in the case of MT3 (Table 2).
To obtain more information about potential factor(s)
that may contribute to food intake-related changes in
MT1 and MT2 gene expressions, we determined serum
concentrations of insulin in control, fasted, and refed
rats. As shown in Fig. 6, fasting was associated with a
significant decrease in serum insulin, whereas refeeding
resulted in an increase of this parameter. An inverse as-
sociation between serum insulin and MT1 and MT2
Fig. 2 The influence of fasting on MT mRNA level in WAT of rats. MT1 (a), MT2 (b), and MT3 (c) mRNA levels relative to β-actin mRNA levels in
retroperitoneal, epididymal, and inguinal WAT of rats fed ad libitum (CN) and fasted rats: 24 h (F24), 48 h (F48), and 72 h (F72) are shown on the
graphs (mean ± S.D., n = 10) *p < 0.05, **p < 0.01, ***p < 0.001 . Note that MT3 mRNA levels in retroperitoneal, epididymal, and inguinal of control
rats were significantly lower than MT1 and MT2
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Fig. 3 The influence of fasting on MT mRNA level in the liver of rats.
MT1 (a) and MT2 (b) mRNA levels relative to β-actin mRNA levels in
the liver of rats fed ad libitum (CN) and fasted rats: 24 h (F24), 48 h
(F48), and 72 h (F72) are shown on the graphs (mean ± S.D., n = 10)
*p < 0.05, **p < 0.01
CN F24  F48 F72
Retroperi-














Fig. 4 The effect of fasting or fasting/refeeding on MT1 and MT2
(MT1/2) protein level in WAT (retroperitoneal, epididymal, inguinal),
liver and serum of rats fed ad libitum (CN) and fasted: 24 hours (F24),
48 hours (F48) and 72 hours (F72). Protein levels were assessed by
Western blotting (two representative samples from each group are
shown). 20 μg of protein per lane was loaded
Szrok et al. Genes & Nutrition  (2016) 11:18 Page 6 of 12mRNA levels in WAT suggests that insulin may influ-
ence, at least partially the expressions of MT1 and MT2
encoding genes. To verify this hypothesis, we studied the
effects of insulin on MT1 and MT2 levels in isolated
adipocytes from epididymal WAT. As shown in Fig. 7,
exposure of adipocytes to insulin (which theoretically
should mimic a fed state) was reflected by a significant
decrease in MT1 mRNA level. When dB-cAMP was
added to the primary culture (which theoretically should
mimic a fasted state), a significant increase in MT1mRNA level was observed (Fig. 7a). Further, addition of
insulin to adipocytes incubated in the presence of dB-
cAMP was reflected by a significant decrease in MT1
mRNA levels. Essentially, similar results were obtained
for MT2 mRNA level (Fig. 7a). Incubation with insulin
or/and dB-cAMP exerted no effects on MT3 mRNA level
in the primary culture of isolated adipocytes (Fig. 7a).
Moreover, MT1 and MT2 mRNA in isolated rat adipocytes
was also upregulated by forskolin (Fig. 7b), a compound
increasing the intracellular cAMP. No significant effect of
forskolin on MT3 mRNA level was found (Fig. 7b).
Discussion
Our present study showed that (a) MT1, MT2, and MT3
isoforms, but not MT4, are expressed in all main fat de-
pots (retroperitoneal, epididymal, and inguinal) of rats, (b)
MT1 and MT2 encoding genes are overexpressed in all
main fat depots of fasted rats, (c) refeeding of fasted rats
leads to a decrease in the expressions of MT1 and MT2
encoding genes in WAT, and (d) expression of MT3 en-
coding gene in retroperitoneal, epididymal, and inguinal
WAT is not affected by fasting/refeeding. The magnitude
of induction of MT1 and MT2 mRNA (and protein) levels
is dependent on adipose tissue localization, since fasting
exerted less prominent effects on MT1 and MT2 mRNA
levels in inguinal (subcutaneous) than in epididymal and
retroperitoneal WAT (Fig. 2a, b). The differences between
MT levels in omental and subcutaneous human adipose
tissue were also reported by Kim et al. [23]. Furthermore,
our data imply that the effects of fasting on MT1 and
MT2 mRNA levels in WAT are generally similar to those
Fig. 5 (See legend on next page.)
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Fig. 5 The influence of fasting or fasting/refeeding on MT1 mRNA level in WAT (a), liver (b, c), MT1 and MT2 (MT1/2) protein level in WAT and
liver of rats (d), zinc level (μg/mg protein) in epididymal WAT (e), ZnT1 mRNA level in epididymal WAT (f), and MTF1 mRNA level in epididymal
WAT(g). MT1 mRNA levels relative to β-actin expression in WAT (retroperitoneal, epididymal, and inguinal) and liver of rats fed ad libitum (CN),
fasted 48 h (F48), and fasted 48 h and refed 12 h (F48 + 12) are shown on the graphs (mean ± S.D., n = 10) *p < 0.05, **p < 0.01, ***p < 0.001; MT1
and MT2 protein level in WAT and liver of rats fed ad libitum (CN), fasted 48 h (F48), and fasted 48 h and refed 12 h (F48 + 12) protein levels were
assessed by western blotting (two representative samples from each group are shown, 20 μg of protein per lane was loaded); ZnT1 and MTF1
mRNA levels relative to β-actin mRNA levels in WAT (epididymal) of rats fed ad libitum (CN), fasted 48 h (F48), and fasted 48 h and refed 12 h
(F48 + 12) are shown on the graphs (mean ± S.D., n = 10)
Table 2 Correlation coefficients between body weight and MT
mRNA level in retroperitoneal, epididymal, or inguinal WAT and
the sum of adipose tissue mass and MT mRNA relative level in
retroperitoneal, epididymal, or inguinal WAT
WAT mRNA Body weight Adipose tissue mass
Szrok et al. Genes & Nutrition  (2016) 11:18 Page 8 of 12observed in the liver (Figs. 2 and 3). Thus, the effect of
fasting on the liver content of MTs presented here con-
firms the results reported previously by Higashimoto et al.
[17] and Kondoh et al. [25] in mice.
Our findings differ considerably from those reported
previously by Trayhurn et al. [44] according to whom
MT1 mRNA levels in epididymal WAT of fasted and
fasted/refed mice were similar to the controls. In con-
trast, our fasted rats presented significantly higher MT1
and MT2 mRNA levels than the control animals. More-
over, we showed that the effects of fasting on MT
mRNA levels are time-dependent, reaching its peak after
a 48-h fast. Thus, one possible explanation for the dis-
crepancy between the data published by Trayhurn et al.
[43] and the results of our study (beside different animal
model used) may be a duration of fasting. In Trayhurn
et al.’s [43] experiment, mice were fasted for up to 16 h.
As shown in Fig. 2, the level of MT1 mRNA (as well as
MT2 RNA) in epididymal WAT increased approximately
twofold after 24-h fast and several fold after 48 and 72 h
fast compare to the control.
The effects of fasting on the expressions of MT1 and
MT2 encoding genes in the liver and WAT (as well as
on the serum concentrations of MT1 and MT2), mea-
sured at both mRNA and protein level, were completely
reversed after a 12-h refeeding ad libitum. This implies
that the expressions of MT1 and MT2 encoding genes
in all main fat depots of rats are highly sensitive to nutri-
tional status. Consequently, the levels of MT1 and MT2
in WAT and blood slightly fluctuate throughout the day
in response to food intake.Table 1 The body and WAT (retroperitoneal, epididymal,
inguinal) mass of control, fasted, fasted and refed rats
Group Body weight (g) Adipose tissue mass (g)
Control (ad libitum) 261 ± 10 6.4 ± 1.1
Fasted 24 h 227 ± 9*** 5.4 ± 1.1*
Fasted 48 h 216 ± 9*** 4.9 ± 1.0*
Fasted 72 h 205 ± 8*** ## 4.1 ± 0.9* #
Fasted 48 h + ad libitum 242 ± 9* ## 4.7 ± 1.4**
The body mass and adipose tissue of rats maintained on fasting and fasting
and refeeding (mean ± S.D., n = 10). *p < 0.05, **p < 0.01, ***p < 0.001
compared to the control group, #p < 0.05, ##p < 0.01 compared to 24-h
fasted groupInterestingly, the results presented here indicate that
the expression of genes encoding MT1 and MT2 regu-
lated by fasting and fasting/refeeding could be independ-
ent of total zinc content in WAT. Induction of gene
encoding MT1 expression in rat brown adipose tissue
[32] and mouse liver [13] independent of zinc has been
also reported previously. However, regarding the fact
that intracellular zinc homeostasis is regulated by MTs
[8, 26, 30], overexpression of genes coding MTs in fasted
rats and subsequently the increase in MTs levels could
decrease free zinc ion (but not total zinc levels) concen-
tration in adipocytes necessary for zinc finger protein
biosynthesis. This may affect zinc finger protein biosyn-
thesis and subsequently, adipose tissue function [48]. It
is well documented that the zinc finger proteins regulate
adipogenesis and lipid metabolism in adipose tissue [48].
Thus, one may suppose that increased MT1 and MT2
levels may lead to decrease in intracellular zinc finger
protein levels and subsequently to inhibition of adipo-
genesis and lipid accumulation in adipose tissue. Dimin-
ished levels of intracellular MTs may lead to the increase
of zinc finger protein levels and subsequently to the acti-
vation of adipogenesis and increase in lipid accumula-
tion in adipose tissue, which in turn may lead to obesity.R p R p
Retroperitoneal MT1 −0.60 <0.001 −0.63 <0.001
MT2 −0.54 <0.01 −0.52 <0.01
MT3 0.12 ns 0.02 ns
Epididymal MT1 −0.66 <0.001 −0.48 <0.01
MT2 −0.52 <0.01 −0.43 <0.02
MT3 −0.12 ns −0.05 ns
Inguinal MT1 −0.82 <0.001 −0.66 <0.001
MT2 −0.83 <0.001 −0.54 <0.01
MT3 0.18 ns 0.12 ns
R correlation coefficients; ns non-significant
Fig. 6 The influence of fasting and fasting/refeeding on insulin
concentration in rat serum. Insulin concentration in serum of rats fed
ad libitum (CN), fasted 48 h (F48), and fasted 48 h and refed 12 h
(F48 + 12) are shown on the graph (mean ± S.D., n = 10) *p < 0.05
Fig. 7 The effect of insulin (Ins) and dB-cAMP (dB) (a) and forskolin (b) in p
mRNA level relative to β-actin mRNA levels in primary rat adipocytes: contr
adipocytes are shown on the graph (mean ± S.D., n = 5) *p < 0.05,**p < 0.01
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MTs (1 and 2) null mice are obese [2, 37].
It should be noted that besides MTs, intracellular zinc
homeostasis may be regulated by zinc transporters,
SLC30A (also named ZnT) and SLC39A (also named
ZIP) [42]. However, the results presented in this paper
indicate no association between MTs and Zn trans-
porter mRNA levels.
Moreover, we showed that a 24-h incubation with dB-
cAMP (or forskolin) results in increase, whereas a 24-h
exposure to insulin leads to decrease in MT1 and MT2
mRNA levels in isolated adipocytes (Fig. 7). Thus, the ef-
fect of cAMP on MT gene expression in isolated rat adi-
pocytes is similar to that reported by Trayhurn [44].
However, in contrast to our results, Trayhurn et al. [44]
found increase in MT gene expressions in rat adipocytes
incubated with insulin. Based on the data indicating that
insulin leads to decrease of cAMP concentrations in adi-
pocytes [12], the data reported by Trayhurn et al. [44]
are difficult to explain. Moreover, our results are in linerimary rat adipocytes on MTs mRNA expression. MT1, MT2, and MT3
ol (CN), dB-cAMP, insulin, dB-cAMP plus insulin, and forskolin-treated
Szrok et al. Genes & Nutrition  (2016) 11:18 Page 10 of 12with data reported by Costarelli et al. [9], who found in-
verse relationship between human plasma insulin and
MT concentrations.
Taken together, the results of our study imply that nutri-
tional status plays a key role in the regulation of MT1 and
MT2 encoding genes in WAT. Inverse relationship be-
tween serum insulin concentration and MTs (1 and 2)
mRNA levels in WAT (Figs. 5a and 6) as well as the
decrease in MT1 and MT2 mRNA levels by insulin in iso-
lated adipocytes (Fig. 7) suggests that the effect of nutri-
tional status on MT1 and MT2 is mediated by insulin.
Previous studies showed that MT promoter has the se-
quence for AP-2 (activating protein-2), a transcription
factor via which cAMP upregulates mRNA level in the
liver [10]. Insulin is likely to suppress MT1 and MT2 en-
coding genes upon binding to adipocyte insulin receptors
and their activation; this results in the phosphorylation of
insulin receptor substrates, activation of the phos-
phatidylinositol kinase 3 (PI3K)-kinase B/Akt (PKB/Akt)-
phosphodiesterase 3B pathway, and degradation of cAMP
in adipocytes [12]. These events lead to a decrease in the
intracellular concentrations of cAMP and resultant de-
crease in MT1 and MT2 mRNA levels. Consequently,
both lack of insulin and insulin insensitivity may upregu-
late MT1 and MT2 encoding genes in WAT of rats. How-
ever, it is not excluded that insulin stimulated glucose
influx into adipocytes could be responsible for the inhib-
ition of gene expression encoding MT1 and MT2 in
WAT. Although our experimental data cannot be directly
extrapolated to humans, the previously reported increase
in MT2a gene expression in the adipose tissue from type 2
diabetic patients [16] and obese subject [7, 11] might be at
least in part associated with insulin insensitivity.
Considering that glucocorticosteroids stimulate the ex-
pression of gene encoding MT1 and MT2 in the liver
[24], one can suppose that fasting-induced increase in
these steroid levels [49] may also at least in part contrib-
ute to the observed upregulation of MTs (1 and 2) in
WAT and liver in vivo.
According to Trayhurn et al. [43], MT is a secretory pro-
tein synthesized in WAT (though the primary structure of
MT is inconsistent with that of the classic secretory pro-
tein), and as such, may exert systemic biological effects.
Our presented findings imply that enhanced expressions
of MT1 and MT2 genes in WAT and liver (observed at
both mRNA and protein levels) correlate strongly with an
increase in the serum concentrations of MT1 and MT2
(Fig. 4). Therefore, liver and WAT might contribute to ele-
vated serum MT levels. Consequently, the results of
our study seem to support the hypothesis that MTs are
secretory products of WAT, as proposed by Trayhurn
et al. [43]. However, it is not excluded that some
amount of MTs are released from blood cells during
the preparation of serum.Conclusions
In conclusion, our findings imply that the genes encod-
ing MT1 and MT2, but not MT3, in retroperitoneal, epi-
didymal, and inguinal WAT of rats are regulated by
nutritional status and that insulin plays an important
role in this process. Changes in MT1 and MT2 mRNA
levels were not related to (a) total zinc concentrations,
(b) MTF1 mRNA level, and (c) Zn transporters mRNA
levels in WAT. This suggests that the regulation of MT1
and MT2 gene expression by fasting and fasting/refeed-
ing may be independent of total zinc concentrations. It
is likely that changes in WAT MT1 and MT2 levels in-
duced by nutritional status could be an important sys-
tem to regulate intracellular distribution, but not total
concentrations of zinc.
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